Amphastar Pharmaceuticals, Inc. (FRA:29A)

Germany · Delayed Price · Currency is EUR

23.82

+0.01 (0.04%)

At close: Feb 20, 2026

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Pharmaceutical Products	731.97M	644.40M	498.99M	419.57M	331.37M
Pharmaceutical Products Growth	13.59%	29.14%	18.93%	26.62%	9.72%
Active Pharmaceutical Ingredients (API)	-	-	-	18.20M	18.48M
Active Pharmaceutical Ingredients (API) Growth	-	-	-	-1.52%	-9.23%
Total	731.97M	644.40M	498.99M	437.77M	349.85M
Total Growth	13.59%	29.14%	13.98%	25.13%	8.53%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
United States	707.68M	635.19M	486.83M	419.87M	333.09M
United States Growth	11.41%	30.47%	15.95%	26.05%	9.25%
China	4.34M	4.51M	4.70M	6.02M	3.16M
China Growth	-3.68%	-4.09%	-21.98%	90.45%	113.44%
France	19.95M	4.70M	7.46M	11.88M	13.59M
France Growth	324.58%	-37.00%	-37.23%	-12.60%	-14.94%
Total	731.97M	644.40M	498.99M	437.77M	349.85M
Total Growth	13.59%	29.14%	13.98%	25.13%	8.53%

Source: S&P Global Market Intelligence.